Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
KI ›
KIENDRA
Trademark search for:
KIENDRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-05-03 — Application filed
2017-05-06 — Application filed
2017-05-08 — Application filed
2017-06-02 — Assigned to examiner
2017-06-09 — Notification of letter of suspension e-mailed
2017-06-09 — Letter of suspension e-mailed
2017-06-09 — Suspension letter written
2018-01-16 — Assigned to lie
2018-01-17 — Report completed suspension check case still suspended
2018-01-26 — Teas response to suspension inquiry received
2018-01-26 — Teas/email correspondence entered
2018-01-26 — Correspondence received in law office
2018-02-23 — Suspension letter written
2018-02-23 — Letter of suspension e-mailed
2018-02-23 — Notification of letter of suspension e-mailed
2018-03-05 — Teas response to suspension inquiry received
2018-03-07 — Correspondence received in law office
2018-03-07 — Teas/email correspondence entered
2018-03-08 — Approved for pub - principal register
2018-03-21 — Notification of notice of publication e-mailed
2018-04-10 — Published for opposition
2018-04-10 — Official gazette publication confirmation e-mailed
2018-06-05 — Noa e-mailed - sou required from applicant
2018-12-04 — Sou teas extension received
2018-12-04 — Sou extension 1 filed
2018-12-04 — Sou extension 1 granted
2018-12-06 — Notice of approval of extension request e-mailed
2019-06-03 — Sou teas extension received
2019-06-03 — Sou extension 2 filed
2019-06-03 — Sou extension 2 granted
2019-06-05 — Notice of approval of extension request e-mailed
2019-12-03 — Sou teas extension received
2019-12-03 — Sou extension 3 filed
2019-12-03 — Sou extension 3 granted
2019-12-05 — Notice of approval of extension request e-mailed
2020-06-04 — Sou teas extension received
2020-06-04 — Sou extension 4 filed
2020-06-04 — Sou extension 4 granted
2020-06-06 — Notice of approval of extension request e-mailed
2021-01-11 — Application abandoned
2021-01-11 — Application abandoned
2021-01-11 — Final status recorded
Owner Information
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
Maury M. Tepper, III TEPPER & EYSTER, PLLC 3724 BENSON DRIVE RALEIGH, NC 27609 UNITED STATES
Filing Details
Filing Date:
2017-05-03
Status Date:
2021-01-11
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.